Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221929 · ClinicalTrials.gov registry record · NA

Exercise-priming of CBT for Depression: the CBT+ Trial

A NA study of Major Depressive Disorder, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07221929: Recruiting NA study of Major Depressive Disorder, sponsored by University of Wisconsin, Madison.

NCT07221929 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221929, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmentation, investigators will conduct a randomized controlled trial involving 100 adults with Major Depressive Disorder who will watch a nature documentary while either resting quietly ( 'CalmCBT') or exercising at a moderate intensity ('ActiveCBT') immediately prior to 8 weekly sessions of CBT.

Primary Outcome

The WAI-Bond subscale scores 4 items, with scores ranging from 4-28. Higher scores are stronger perceived patient-therapist bond: how the participant experiences feelings of bond (i.e., feelings of mutual trust, acceptance, and connection) with their therapist.. The Bond subscale is a primary outcome measure for this study and the total score will be analyzed as a secondary outcome.

Conditions Studied

Interventions

  • BEHAVIORAL Rest
  • BEHAVIORAL Aerobic Activity

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-01-05
Est. Completion 2029-12
Phase NA
University of Wisconsin, Madison

1,039 total trials

What NCT07221929 shows while recruiting

NCT07221929 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Rest is the first listed.

NCT07221929 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT07221929 about?

NCT07221929 is a clinical study titled "Exercise-priming of CBT for Depression: the CBT+ Trial". This study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmentation, investigators ...

What is the current status of trial NCT07221929?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-01-05. Estimated completion is 2029-12.

What conditions does trial NCT07221929 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT07221929?

The interventions under investigation include: Rest (BEHAVIORAL), Aerobic Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT07221929?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07221929 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07221929's enrollment target sits among peer trials

100 132nd of 282 higher than 145 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07221929, the US trial registry maintained by the National Library of Medicine. NCT07221929 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.